24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
David Mamo, Centre for Addiction and Mental Health
ClinicalTrials.gov Identifier:
NCT00818298
First received: January 6, 2009
Last updated: July 6, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
No publications provided by Centre for Addiction and Mental Health

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):